Evaluating the Relationship Between Sleep-Disordered Breathing and Daytime Alertness
Relating Sleep Disordered Breathing to Daytime Function
연구 개요
상세 설명
Individuals with OSA can experience up to 300 sleep disruptions each night, which may result in excessive daytime sleepiness (EDS), one of the most common symptoms of OSA. EDS can have serious consequences, including motor vehicle accidents, poor school performance, and work-related accidents and performance issues. The most common treatment for OSA is CPAP therapy. This involves wearing a mask over the nose while sleeping; air then flows through the mask into the nose to maintain a level of pressure that keeps the breathing passages open. CPAP therapy typically results in fewer sleep and breathing disruptions during the night, which may increase an individual's alertness levels during the day. The purpose of this study is to evaluate the relationship between severity of sleep-disordered breathing and daytime alertness levels in adults with and withoutout symptoms of OSA.
This study will involve three to five study visits over a 2- to 3-month period. During the first 3 days, participants will record their sleep habits in a diary and will wear a device that measures breathing, oxygen levels, and sleep position. All participants will then take part in a 1-night inpatient stay at the sleep center lab during which brain, eye, muscle, heart, and breathing activity will be monitored. Participants with a confirmed diagnosis of OSA will stay at the sleep lab one additional night for observation while using a CPAP machine. The following day, tests to measure alertness, ease of falling asleep, and sleepiness levels will be administered. Participants will then use the CPAP machine at home for 4-6 weeks; each machine will be set at an appropriate level for the participant, and will record breathing patterns and pressure. Participants will receive weekly phone calls for monitoring purposes. At the end of Week 4, participants will return to the sleep lab for one additional night of CPAP monitoring, followed by alertness and sleep testing. Those with severe OSA will use the CPAP machine at a newly adjusted level for 5 additional days and return for repeat testing. All participants who have been compliant with CPAP will return to the lab for overnight sleep testing without the CPAP machine and for alertness testing.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
New York
-
New York, New York, 미국, 10016
- NYU Sleep Disorders Center
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Experiences symptoms of OSA, including snoring and sleepiness
- Stable medical history with no change in medications that could affect sleepiness
Exclusion Criteria:
- Suspected diagnosis of a sleep disorder other than OSA (i.e., periodic leg movements, narcolepsy, insomnia, central sleep apnea, sleep hypoventilation syndrome)
- Medically unstable health conditions (e.g., heart attack, congestive heart failure)
- Use of psychotropic medications that cause sedation in the 3 months prior to study entry
- Recent or confirmed history of recreational drug use or alcohol abuse
- Pregnant
- Inability to communicate verbally, write, or read
- Visual, hearing, or cognitive impairment
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Continuous Positive Airway Pressure (CPAP)
Participants will use a CPAP machine if they are found to have sleep apnea.
|
Positive airway pressure delivered via a nasal mask titrated to a therapeutic level to eliminate all sleep disordered breathing to be used every night for 4-6 weeks.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Subjective Sleepiness
기간: Baseline, CPAP( 4 -6 weeks), Off CPAP ( 2 nights)
|
Measured using the Epworth sleepiness scale (ESS).
The Epworth sleepiness scale is used in the assessment of daytime sleepiness and measures the general level of sleepiness.The ESS presents the subject with eight situations and asks how likely they are to fall asleep (0= never, 1 =slight chance of dozing, 2= moderate chance of dozing and 3 =high chance of dozing) in these situations.
The sum of the 8 answers is used as the score and ranges from 0 (not sleepy) to 24 (extremely sleepy), and a score of greater than 10 is an indication that a person may be excessively sleepy.
|
Baseline, CPAP( 4 -6 weeks), Off CPAP ( 2 nights)
|
|
Objective Sleepiness
기간: Measured at baseline, on CPAP (4-6 weeks), CPAP withdrawal (2 nights)
|
Multiple Sleep Latency Test (MSLT) measures the latency to sleep onset in minutes.
The shorter the latency to sleep the more sleepy the subject.
|
Measured at baseline, on CPAP (4-6 weeks), CPAP withdrawal (2 nights)
|
|
Vigilance
기간: Baseline, CPAP (4-6 weeks), CPAP withdrawal (2 nights)
|
Vigilance is measured using the psychomotor vigilance task which is a portable reaction time test that is contained in a small, programmable, portable electronic box that requires only a single switch to start.
The task consists of responding to a small bright red light stimulus by pressing a response button as soon as the stimulus appears.
This stops the stimulus counter and displays the reaction time (RT) in milliseconds for a 2-second period and the task duration is 20 minutes.
The subject is instructed to press the button as soon as each stimulus appears in order to keep the reaction time as low as possible.
The PVT yields highly informative metrics on the capacity for sustained attention including the frequency of lapses (reaction time > 500 milliseconds).
The higher the number of lapses the greater the impairment.
Well rested (non-sleepy) subjects have almost no lapses(<2) during the 20min test.
|
Baseline, CPAP (4-6 weeks), CPAP withdrawal (2 nights)
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Indu Ayappa, PhD, NYU School of Medicine
간행물 및 유용한 링크
일반 간행물
- Somiah M, Taxin Z, Keating J, Mooney AM, Norman RG, Rapoport DM, Ayappa I. Sleep quality, short-term and long-term CPAP adherence. J Clin Sleep Med. 2012 Oct 15;8(5):489-500. doi: 10.5664/jcsm.2138.
- Young LR, Taxin ZH, Norman RG, Walsleben JA, Rapoport DM, Ayappa I. Response to CPAP withdrawal in patients with mild versus severe obstructive sleep apnea/hypopnea syndrome. Sleep. 2013 Mar 1;36(3):405-12. doi: 10.5665/sleep.2460.
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Continuous Positive Airway Pressure (CPAP)에 대한 임상 시험
-
University Hospital, GrenobleONIRIS종료됨
-
Edward KasaraskisNational Institute of Neurological Disorders and Stroke (NINDS)완전한
-
Children's Hospitals and Clinics of Minnesota종료됨
-
Daping Hospital and the Research Institute of Surgery...알려지지 않은
-
University of British Columbia빼는
-
University of VirginiaONY; LMA North America종료됨